Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients

Virus Research

Volumn 145, Issue 2, 2009, Pages 260-269

  Kong, Say Li ^a   Chui, Paul ^b   Lim, Bing ^a,c   Salto Tellez, Manuel ^d  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b HEALTH SCIENCES AUTHORITY   (Singapore)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

^d NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

ARDS; Pathogenesis; SARS CoV infection; Therapeutic interventions

Indexed keywords

CASPASE 3; CASPASE 9; CD14 ANTIGEN; CD68 ANTIGEN; COMPLEMENT COMPONENT C1Q; CORTICOSTEROID; DEXAMETHASONE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; INTERFERON; INTERFERON REGULATORY FACTOR 3; KERATINOCYTE GROWTH FACTOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SOMATOMEDIN C; STAT1 PROTEIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; APOPTOSIS; ARTICLE; AUTOPSY; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON PRODUCTION; LUNG FIBROSIS; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; UPREGULATION;

ADULT; AGED; AUTOPSY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERITY OF ILLNESS INDEX;

SARS CORONAVIRUS;

EID: 70349383903     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.07.014     Document Type: Article

References (31)

1. Aichele D., Schnare M., Saake M., Rollinghoff M., and Gessner A. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect. Immun. 74 8 (2006) 4708-4714
2. Armbrust T., Nordmann B., Kreibig M., and Ramadori G. C1Q synthesis by tissue mononuclear phagocytes from normal and from damaged rat liver: up-regulation by dexamethasone, down-regulation by interferon gamma, and lipopolysaccharide. Hepatology 26 (1997) 98-106
3. Asano S., Kida K., Koyama T., Wada H., Izawa Y., Hosoda K., Masuda K., and Suzuki Y. A morphological study of lung secretory leukoprotease inhibitor in pneumonia. Am. J. Respir. Crit. Care Med. 151 (1995) 1576-1581
4. Bauvois B., and Dauzonne D. Aminopeptidase-N/CD13 inhibitors: chemistry, biological evaluations, and therapeutic prospects. Med. Res. Rev. 26 1 (2006) 88-130
5. Bhatia M., and Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol. 202 (2004) 145-156
6. 3. J. Biol. Chem. 277 (2002) 39899-39908
7. Cheng T., Brzostek S., Ando O., Scoy S.V., Kumar K.P., and Reich N.C. Differential activation of IFN regulator factor (IRF)-3 and IRF-5 transcription factors during viral infection. J. Immunol. 176 (2006) 7462-7470
8. 3 receptor agonists induced microvascular leakage hypersensitivity in the guinea-pig airways. Eur. J. Pharmacol. 433 (2001) 199-207
9. de Lang A., Baas T., Teal T., Leijten L.M., Rain B., Osterhaus A.D., Haagmans B.L., and Katze M.G. Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques. PLoS Pathog. 3 8 (2007) e112
10. Deree J., Lall R., Melbostad H., Grant M., Hoyt D.B., and Coimbra R. Neutrophil degranulation and the effects of phosphodiesterase inhibition. J. Surg. Res. 133 (2006) 22-28
11. Ding Y., He L., Zhang Q., Huang Z., Che X., Hou J., Wang H., Shen H., Qiu L., Li Z., Geng J., Cai J., Han H., Li X., Kang W., Weng D., Liang P., and Jiang S. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203 (2004) 622-630
12. Eaton J.W., Brandt P., Mahoney J.R., and Lee J.T. Haptoglobin: a natural bacteriostat. Science 215 (1982) 691-693
13. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in anti-bacterial host defense. J. Leuk. Biol. 64 (1998) 14-18
14. Frosch M., Strey A., Vogl T., Wulffraat N.M., Kuis W., Sunderkötter C., Harms E., Sorg C., and Roth J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 43 (2000) 628-637
15. Fukuda R., Hirota K., Fan F., Jung Y.D., Ellis L.M., and Semenza G.L. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277 (2002) 38205-38211
16. Glass W.G., Subbarao K., Murphy B., and Murphy P.M. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection in mice. J. Immunol. 173 (2004) 4030-4039
17. Ksiazek T.G., Erdman D., Goldsmmoth C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A., Humphrey C.D., Shieh W., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., Anderson L.J., and SARS Working Group. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348 (2003) 1953-1966
18. Levy D.E., and Darnell J.E.J. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3 (2002) 651-662
19. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., and Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003) 450-454
20. Ng P.C., Lam C.W.K., Li A.M., Wong C.K., and Cheng F.W.T. Inflammatory cytokine profile in children with severe acute respiratory syndrome. Pediatrics 113 (2004) 7-14
21. O'Neill L.A.J. How toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18 (2006) 3-9
22. Platt N., Suzuki H., Kurihara Y., Kodama T., and Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 12456-12460
23. Reghunathan R., Jayapal M., Hsu L.Y., Chng H.H., Tai D., Leung B.P., and Melendez A.J. Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunol. 6 (2005) 2
24. Sallenave J.M., Donnelly S.C., Grant I.S., Robertson C., and Gauldie J. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome. Eur. Respir. J. 13 (1999) 1029-1036
25. Salto-Tellez M., Tan E., and Lim B. ARDS in SARS: cytokine mediators and treatment implications. Cytokine 29 (2005) 92-94
26. Samoszuk M., Kanakubo E., and Chan J.K. Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer 5 (2005) 121
27. Senaldi G., Stolina M., Guo K., Faggioni R., McCabe S., Kaufman S.A., Van G., Xu W., Fletcher F.A., Boone T., Chang M., Sarmiento U., and Cattley R.C. Regulatory effects of novel neurotrophin-1/b cell-stimulating factor-3 (cardiotrophin-like cytokine) on B cell function. J. Immunol. 168 (2002) 5690-5698
28. Springer J., Groneberg D.A., Pregla R., and Fischer A. Inflammatory cells as source of tachykinin-induces mucus secretion in chronic bronchitis. Regul. Pept. 124 (2005) 195-201
29. Vanguri P., and Farber J.M. Identification of CRG-2: an interferon-inducible mRNA predicted to encode a murine monokine. J. Biol. Chem. 265 (1990) 15049-15057
30. Vijgen L., Keyaerts E., Zlateva K., and Van Ranst M. Identifiation of 6 new polymorphisms in the human coronavirus 229E receptor gene. Int. J. Infect. Dis. 8 (2004) 217-222
31. WHO, 2003. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Available: http://www.who.int.